24 May 2019 by admin in UncategorizedComments Crescendo Biologics Achieves Another Milestone in its Strategic Collaboration with Takeda
19 May 2019 by admin in UncategorizedComments Crescendo awarded with EU patent on immunoglobulin libraries from transgenic animals
16 May 2019 by admin in UncategorizedComments TEMPEST THERAPEUTICS STARTS PHASE I/IB CLINICAL TRIAL WITH FIRST-IN-CLASS PPAR ALPHA ANTAGONIST
15 May 2019 by admin in UncategorizedComments resTORbio Reports First Quarter 2019 Financial Results and Corporate Update
08 May 2019 by admin in UncategorizedComments NextCure Announces Pricing of Initial Public Offering of Common Stock
01 May 2019 by admin in UncategorizedComments Syros Reports First Quarter 2019 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
02 Apr 2019 by admin in UncategorizedComments Theodora Harold to be appointed new CEO at Crescendo Biologics
15 Mar 2019 by admin in UncategorizedComments Crescendo Biologics wins in “Life Science Innovation” category at the Business Weekly Awards 2019
07 Mar 2019 by admin in UncategorizedComments Syros Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Multiple Upcoming Clinical Milestones for Its First-in-Class Programs
04 Mar 2019 by admin in UncategorizedComments NextCure and Yale Publish Nature Medicine Paper Detailing Novel Immunomedicine Target Siglec-15
